The Signal Expert insights and opinions on clinical research and drug development. Expert insights and opinions on clinical research and drug development. Signant Health’s Clinical Scientist Jennifer Olt Receives ISCTM New Investigator Award May 11, 2022 Signant Health Posted in Scientific Advisory Jennifer Olt, Ph.D., a Clinical Scientist from Signant Health’s Operations – Clinical Science team, accepted a 2022 New Investigator Award… Read More Patient-Reported Outcomes in Medical Device Trials – What We Can Learn From the FDA Guidance May 10, 2022 Bill Byrom Posted in eCOA Patient-reported outcomes data are increasingly collected in medical device clinical trials. In their strategic priorities document [1], the FDA’s Center… Read More Measurement Comparability of Electronic and Paper Administration of Visual Analogue Scales: A Review of Published Studies March 21, 2022 Bill Byrom Posted in eCOA Visual analogue scales (VASs) in clinical trials ask patients to mark a position on a horizontal line to reflect how… Read More Leveraging the Power of Real-Time Data Aggregation: Virtual Event Recap March 2, 2022 Signant Health Posted in Events Recently, Signant hosted a virtual event exploring topics in clinical data management. Introducing the concept of data aggregation underpinning Signant’s… Read More Dealing with Missing Data from Sensors and Wearables January 31, 2022 Bill Byrom Posted in Sensors & Wearables The potential of using sensors and wearables in developing clinical trial measures to better understand the effects of new treatment… Read More The Winter Imagine Forum Recap January 28, 2022 Signant Health Posted in Events For Signant Health’s second Imagine Forum, we focused on how the industry can leverage direct-to-patient (DtP) clinical supply approaches to… Read More 5 Tips for Success in Rare Disease Studies January 14, 2022 Joan Busner Posted in Scientific Advisory Before you begin planning your rare disease study, it’s important to identify potential challenges. At Signant, we believe that the… Read More Clinical Data Fraud: Detection & Mitigation Strategies January 5, 2022 Bill Byrom Posted in eCOA One of the most compelling arguments for using electronic data capture methods for patient-reported outcome assessments (ePRO) is the ability to ensure and demonstrate data integrity. Electronic data collection allows study teams to use… Read More Webinar Recap: Applying Advanced Analytics to Overcome CNS Trial Challenges December 20, 2021 Signant Health Posted in Data Analytics If you missed Signant’s webinar on applying analytics to CNS clinical trials, you’re in luck – we’ve summarized the key… Read More The Center for Drug Evaluation’s (CDE) draft PRO guidance December 16, 2021 Bill Byrom Posted in eCOA In the landscape of rapidly growing numbers of pharmaceutical clinical trials in China, the Chinese Center for Drug Evaluation (CDE)… Read More Previous 1 2 3 4 5 6 Next
Signant Health’s Clinical Scientist Jennifer Olt Receives ISCTM New Investigator Award May 11, 2022 Signant Health Posted in Scientific Advisory Jennifer Olt, Ph.D., a Clinical Scientist from Signant Health’s Operations – Clinical Science team, accepted a 2022 New Investigator Award… Read More Patient-Reported Outcomes in Medical Device Trials – What We Can Learn From the FDA Guidance May 10, 2022 Bill Byrom Posted in eCOA Patient-reported outcomes data are increasingly collected in medical device clinical trials. In their strategic priorities document [1], the FDA’s Center… Read More Measurement Comparability of Electronic and Paper Administration of Visual Analogue Scales: A Review of Published Studies March 21, 2022 Bill Byrom Posted in eCOA Visual analogue scales (VASs) in clinical trials ask patients to mark a position on a horizontal line to reflect how… Read More Leveraging the Power of Real-Time Data Aggregation: Virtual Event Recap March 2, 2022 Signant Health Posted in Events Recently, Signant hosted a virtual event exploring topics in clinical data management. Introducing the concept of data aggregation underpinning Signant’s… Read More Dealing with Missing Data from Sensors and Wearables January 31, 2022 Bill Byrom Posted in Sensors & Wearables The potential of using sensors and wearables in developing clinical trial measures to better understand the effects of new treatment… Read More The Winter Imagine Forum Recap January 28, 2022 Signant Health Posted in Events For Signant Health’s second Imagine Forum, we focused on how the industry can leverage direct-to-patient (DtP) clinical supply approaches to… Read More 5 Tips for Success in Rare Disease Studies January 14, 2022 Joan Busner Posted in Scientific Advisory Before you begin planning your rare disease study, it’s important to identify potential challenges. At Signant, we believe that the… Read More Clinical Data Fraud: Detection & Mitigation Strategies January 5, 2022 Bill Byrom Posted in eCOA One of the most compelling arguments for using electronic data capture methods for patient-reported outcome assessments (ePRO) is the ability to ensure and demonstrate data integrity. Electronic data collection allows study teams to use… Read More Webinar Recap: Applying Advanced Analytics to Overcome CNS Trial Challenges December 20, 2021 Signant Health Posted in Data Analytics If you missed Signant’s webinar on applying analytics to CNS clinical trials, you’re in luck – we’ve summarized the key… Read More The Center for Drug Evaluation’s (CDE) draft PRO guidance December 16, 2021 Bill Byrom Posted in eCOA In the landscape of rapidly growing numbers of pharmaceutical clinical trials in China, the Chinese Center for Drug Evaluation (CDE)… Read More Previous 1 2 3 4 5 6 Next